Morning all,
Not to cross promote, but DXB is also presenting at the Bioshares Biotech Summit today and they have released an event-specific preso that includes some interesting info about global partnering trends and the mechanics of licensing deals in the healthcare/life sciences space, which I found relevant to NEU so I thought I’d share.g
Link to full presentation available here:
https://investors.dimerix.com/DownloadFile.axd?file=/Report/ComNews/20240712/02827240.pdf
Also, it’s 2 years to the day since the NNZ-2591 Phase 2 trial in Angelman Syndrome commenced. We must be getting close to a result. Link to that announcement:
https://www.neurenpharma.com/pdf/d9b6c1d7-c009-441c-bf1a-538251f82f7d/Neuren-commences-Phase-2-trial-of-NNZ2591-in-Angelman.pdf
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
Neuren Media and Analyst Coverage, page-1239
-
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 3429 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 18.000 |
2 | 582 | 17.950 |
2 | 650 | 17.500 |
1 | 100 | 17.150 |
2 | 3116 | 17.100 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 3429 | 4 |
15.400 | 15 | 1 |
15.500 | 2500 | 1 |
15.800 | 1425 | 1 |
16.000 | 7061 | 2 |
Last trade - 16.16pm 08/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable